Stonegate Investment Group, LLC Haemonetics Corp Transaction History
Stonegate Investment Group, LLC
- $3.67 Billion
- Q3 2024
A detailed history of Stonegate Investment Group, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Stonegate Investment Group, LLC holds 2,717 shares of HAE stock, worth $227,901. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,717
Previous 2,589
4.94%
Holding current value
$227,901
Previous $214,000
1.87%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding HAE
# of Institutions
333Shares Held
54MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$500 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$434 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$373 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$352 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$338 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.3B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...